Zygomatic and Pterygoid Implants Market | Worldwide Industry Analysis and New Market Opportunities Explored

A report by Transparency Market Research predicts The Global Zygomatic And Pterygoid Implants Market to rise at a steady CAGR of 5.9% during the period between 2017 and 2025 to become worth US$350.2 mn by 2025 from US$211.4 mn in 2016. The zygomatic technique steals a march over conventional implant techniques on account of many unique perceived benefits. First, it takes just 72 hours to fix a row of teeth as compared to almost 6 months in conventional technique. Second, it does not require bone graft. Third, it reduces discomfort drastically and allows people to chew or bite crunchy food almost immediately. Overall, Zygomatic and pterygoid implants serve to bring about aesthetically improved results for patients with atrophic edentulous maxilla. The treatment is easy enough and recovery time is faster.

“The success rate of zygomatic implants is over 95%. Rising benefits of zygomatic implants over conventional implants and high success rate are expected to drive the market during the forecast period,” adds the lead analyst of the report. Other factors such as changing demographics and rising disposable income, increasing dental injuries, and aesthetic awareness are also proving beneficial for the market. Currently, multispecialty hospitals are majorly fuelling growth in the global zygomatic and pterygoid implants market. This is because they are well stocked with surgical instruments, specialty care, and general anesthesia that are required for zygomatic implant procedure.

Request to view Sample Report –


Geographically, the key segments of the global market for zygomatic and pterygoid implants are North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Europe, of them, currently accounts for maximum share in the market. It is also slated to register maximum CAGR of 6.2% from 2017 to 2025 to retain its leading share in the market in the foreseeable future. The market in the region is being catapulted to the fore by the ever-increasing pharmaceutical companies focusing development of new and advanced dental implants for atrophy of maxillofacial bone.

Danaher Corporation, Straumann Holding AG, Noris Medical, S.I.N. Implant System, Silimed, Southern Implants, Implance, Jeil Medical Corporation, and Titaniumfix are to name a few prominent participants operating in the global market for zygomatic and pterygoid implants.

Zygomatic and Pterygoid Implants Market Report is available @ US$ 5795


%d bloggers like this: